ClinicalTrials.govpublic full text
Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(11;14) Genetic Stratification
multiple myeloma (mm), bcma/cd3 bispecific antibody, sonrotoclax, t(11;14), interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 982262
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.